103 filings
Page 4 of 6
S-8
9h70voki m2
2 Aug 19
Registration of securities for employees
5:28pm
S-3
9h8nkh0
2 Aug 19
Shelf registration
5:26pm
8-K
sy713af
1 Aug 19
Eidos Therapeutics Reports Second Quarter 2019 Financial Results
4:31pm
8-K
qerxjhted
17 Jun 19
Departure of Directors or Certain Officers
4:03pm
8-K
9tjcn2 w6kc696xqviy
7 May 19
Eidos Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
DEF 14A
5g4kbu dok2may
29 Apr 19
Definitive proxy
4:23pm
10-K
0dzq9
15 Apr 19
Annual report
8:37am
8-K
vgspg2vika69v it1
15 Apr 19
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
8:30am
NT 10-K
ulgmhk
1 Apr 19
Notice of late annual filing
5:09pm
8-K
f9o1bwd
1 Apr 19
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:06pm
8-K
0nqs 7fpknv7esl2e
27 Feb 19
Other Events
7:00am
8-K
ja5il70i5m7 6fnzrmm
21 Feb 19
Changes in Registrant's Certifying Accountant
9:00am
8-K
umfz6ebeg4qfh8v
6 Dec 18
Eidos Therapeutics Appoints William Lis to Board of Directors
4:15pm
8-K
4enqqzo td0qvvl6y
13 Nov 18
Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy
6:05am
8-K
ukosfbte9i1 9x9o93
6 Nov 18
Results of Operations and Financial Condition
4:30pm
8-K
cduq47osijp hsi
7 Aug 18
Results of Operations and Financial Condition
12:00am
10-Q
g8840dzf3jji
7 Aug 18
Quarterly report
12:00am